Skip to main content
All lobbying firms

CRANE STRATEGIES

Registrant on federal lobbying filings · filed 2025 to 2026

$870,000 Income reported
2 Clients represented
14 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (400927689), not by name.

 Clients 2
 Lobbyists named 1
  • STEVEN CRANE 14 filings · through 2026 Subcommittee clerk, House Committee on Appropriations

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $390,000 6 filings
  • 2025 $480,000 8 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • Health & Human Services, Dept of (HHS) 14
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
 Recent filings 14 total
Q3 report
REGENERON PHARMACEUTICALS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Nov 3, 2026
View → Q3 report
SIGA TECHNOLOGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Nov 3, 2026
View → Q2 report
REGENERON PHARMACEUTICALS, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Aug 3, 2026
View → Q2 report
SIGA TECHNOLOGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Aug 3, 2026
View → Q1 report
REGENERON PHARMACEUTICALS, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted May 4, 2026
View → Q1 report
SIGA TECHNOLOGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted May 4, 2026
View → Q4 report
REGENERON PHARMACEUTICALS, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 21, 2026
View → Q4 report
SIGA TECHNOLOGIES
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 21, 2026
View → Q3 report
REGENERON PHARMACEUTICALS, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 1, 2025
View → Q3 report
SIGA TECHNOLOGIES
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 1, 2025
View → Q2 report
REGENERON PHARMACEUTICALS, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 1, 2025
View → Q2 report
SIGA TECHNOLOGIES
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 1, 2025
View → Q1 report
REGENERON PHARMACEUTICALS, INC.
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted May 5, 2025
View → Q1 report
SIGA TECHNOLOGIES
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted May 5, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem